Biodelivery Sciences International Total Revenue

The latest total revenue for BDSI is $170M as of December 2021. That compares with $160M in the prior-year period — up 6.5% year over year. That is below the Healthcare sector average of $110B. Investors often review this figure alongside Biodelivery Sciences International's historical trend and sector peers before judging valuation or financial health.

Over the past year, BDSI's total revenue moved from $160M to $170M — a 6.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Biodelivery Sciences International's operating scale or balance-sheet position.

Against Healthcare companies, BDSI currently prints $170M for total revenue, while the sector average sits near $110B. That is roughly 99.8% below the sector mean. Large gaps often invite a closer look at Biodelivery Sciences International's growth, margins, and balance sheet.

A total revenue figure of $170M for BDSI is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $110B. Explore the charts below for those layers of context.

After noting BDSI's total revenue ($170M), review year-over-year change from $160M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.